Clinical Trials Browser

Phase 2 × dalotuzumab × Endocrine × Clear all

NCT00610129 2015-11-20

Clinical and Translational Study of MK-0646 in Patients With Metastatic Neuroendocrine Tumors (NET)

Phase 2 Completed

25 enrolled 6 charts

Neuroendocrine Tumors